Markers of Coronary Artery Disease During Exercise Testing

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

327 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-12-31

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of this study is to examine whether changes in biomarkers during exercise are related to coronary artery disease demonstrated by coronary angiography or echocardiography.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers

NCT04144725

Coronary Artery Disease

RECRUITING

Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction

NCT04167904

Myocardial Infarction, Acute

COMPLETED

Myocardial Ischemia in Non-obstructive Coronary Artery Disease

NCT01853527

Coronary Atherosclerosis Myocardial Ischemia

COMPLETED

Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease

NCT02626806

Coronary Artery Disease

UNKNOWN

Diagnostic Performance of Exercise Stress Tests for the Detection of Epicardial and Microvascular Coronary Artery Disease

NCT05231161

Coronary Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chest pain/discomfort is a common patient complaint in patients referred to outpatient clinics and emergency departments. The initial goal of evaluation is to exclude potential life threatening conditions like coronary artery disease. Exercise stress testing is a widely available non-invasive test in patients with chest pain and suspected coronary artery disease. However, the sensitivity and specificity of the test is relatively low. Exercise seems to cause an increase in the secretion of B-type natriuretic peptide (BNP), and myocardial ischemia may lead to an even more pronounced increase. Investigators aim to examine whether changes in bloodborne biomarkers such as NT-pro-BNP during exercise may improve the accuracy of exercise stress testing in patients with chest pain/discomfort and a clinical suspicion of coronary artery disease. Also, investigators aim to examine whether changes in biomarkers during exercise are related to cardiac disease demonstrated by echocardiography.

It is known that sudden heavy physical load can trigger myocardial infarction, especially in untrained individuals. The underlying mechanisms are poorly understood and may partly be related to changes in inflammation and haemostasis in patients with coronary artery disease. By measuring markers of inflammation and haemostasis during exercise stress testing, investigators hope to gain new insights into mechanisms responsible for exercise-related myocardial infarction.

Investigators also aim to do a follow-up study to investigate whether results of the initial examinations can relate to future risk of cardiovascular morbidity and mortality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Cardiovascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients referred to Oslo University Hospital Ullevål with chest pain/discomfort of unknown etiology and and a clinical suspicion of coronary artery disease.
* Intermediate or high pre test probability of coronary artery disease.
* Able to give informed, written consent.

Exclusion Criteria

* Not able to perform the exercise test.
* Evidence of acute coronary syndrome.
* Known coronary artery stenosis where exercise testing is contraindicated.
* The presence of known moderate to severe valvular heart disease.
* Known heart failure or obvious clinical signs of heart failure.
* Ongoing atrial fibrillation or atrial flutter.
* Complete or partial bundle branch block.
* Digitoxin therapy.
* Pacemaker.
* Renal insufficiency (S-creatinine \>150 micromol/L).
* Known pregnancy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No